Benzinga - Gainers
- Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday . Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus contingent value rights (CVRs) of up to $8.00 per share.
- Freight Technologies, Inc. (NASDAQ: FRGT) shares climbed 113.6% to close at $0.4410 on Monday after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
- ToughBuilt Industries, Inc. (NASDAQ: TBLT) shares gained 72.3% to close at $3.79 after the company reported better-than-expected Q3 EPS results.
- Exela Technologies, Inc. (NASDAQ: XELA) jumped 45.6% to close at $0.4048.
- Porch Group, Inc. (NASDAQ: PRCH) rose 37.3% to close at $1.40. The compamy recently posted a wider-than-expected quarterly loss.
- Mercurity Fintech Holding Inc. (NASDAQ: MFH) gained 36.1% to close at $0.7358.
- Clovis Oncology, Inc. (NASDAQ: CLVS) rose 32.6% to close at $0.3846. Clovis Oncology recently warned of a possible bankruptcy amid liquidity concerns.
- Getty Images Holdings, Inc. (NYSE: GETY) gained 31.3% to close at $6.97 after the company reported worse-than-expected Q3 results.
- Cabaletta Bio, Inc. (NASDAQ: CABA) jumped 30.7% to close at $3.11. Cabaletta Bio recently posted a Q3 loss of $0.39 per share.
- MINISO Group Holding Limited (NYSE: MNSO) jumped 29% to close at $9.12 after the company reported better-than-expected Q1 financial results.
- Meta Materials Inc. (NASDAQ: MMAT) surged 29% to close at $1.69.
- Yiren Digital Ltd. (NYSE: YRD) gained 27.7% to close at $1.29.
- Insignia Systems, Inc. (NASDAQ: ISIG) jumped 27.7% to close at $8.34. Insignia Systems recently posted Q3 EPS of $6.57.
- Siyata Mobile Inc. (NASDAQ: SYTA) rose 26.9% to close at $0.1650, possibly on continued strength after Zacks Small-Cap Research set a $2.50 price target on the stock.
- PDS Biotechnology Corporation (NASDAQ: PDSB) gained 26.1% to close at $7.06 after the company announced 100% clinical response in cervical cancer patients in preliminary data from the IMMUNOCERV Phase 2 clinical trial. The company also reported better-than-expected Q3 EPS results.
- Onconova Therapeutics, Inc. (NASDAQ: ONTX) gained 25.8% to close at $0.88 following Q3 results.
- Immersion Corporation (NASDAQ: IMMR) jumped 23.6% to close at $6.81. Immersion posted Q3 EPS of $0.28.
- HireRight Holdings Corporation (NYSE: HRT) climbed 23.5% to close at $9.52. HireRight’s board authorized a $100 million share repurchase program.
- Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 22.8% to close at $2.37 after the company announced it received written guidance from the FDA that an acute pain indication may be appropriate for its lead Trypsin Activated Abuse Protection product, PF614.
- Starbox Group Holdings Ltd. (NASDAQ: STBX) jumped 20.6% to close at $2.11.
- Cosmos Holdings Inc. (NASDAQ: COSM) gained 20.3% to close at $0.1480 after gaining 7% on Friday.
- CNFinance Holdings Limited (NYSE: CNF) gained 19.7% to close at $1.70.
- Gaotu Techedu Inc. (NYSE: GOTU) surged 19.2% to settle at $0.8888.
- T2 Biosystems, Inc. (NASDAQ: TTOO) jumped 18.4% to settle at $2.25.
- Kidpik Corp. (NASDAQ: PIK) climbed 18% to close at $1.05. KIDPIK is expected to release Q3 results on November 15, 2022.
- GlycoMimetics, Inc. (NASDAQ: GLYC) gained 16.9% to close at $1.45.
- Agenus Inc. (NASDAQ: AGEN) climbed 16.7% to close at $2.93. Agenus recently posted a Q3 loss of $0.19 per share.
- Clear Secure, Inc. (NYSE: YOU) rose 16.6% to close at $29.69 after the company reported better-than-expected Q3 sales results.
- Dingdong (Cayman) Limited (NYSE: DDL) surged 16.2% to close at $4.08. The company recently reported better-than-expected Q3 adjusted EPS results.
- CIRCOR International, Inc. (NYSE: CIR) gained 14.9% to close at $24.90 following better-than-expected quarterly results.
- CureVac N.V. (NASDAQ: CVAC) gained 12.5% to close at $8.27.
- Armata Pharmaceuticals, Inc. (NYSE: ARMP) gained 11.9% to close at $3.21. Armata Pharmaceuticals recently reported a Q3 loss of $0.24 per share.
- Helius Medical Technologies, Inc. (NASDAQ: HSDT) climbed 11.5% to close at $0.2899 following strong quarterly results.
- HUTCHMED (China) Limited (NASDAQ: HCM) climbed 10.9% to close at $10.98 after the company reported initial results from FRUTIGA. The company said the trial met one of the primary endpoints of statistically significant improvement in progression-free survival.
- Daseke, Inc. (NASDAQ: DSKE) rose 9.7% to close at $6.55. Daseke said that the company has entered into an agreement with its Founder, Mr. Don R. Daseke, and his affiliates, to repurchase their total holdings in the company at a purchase price of $6 per share.
- TAL Education Group (NYSE: TAL) climbed 8.8% to close at $5.18.
- Xinyuan Real Estate Co., Ltd. (NYSE: XIN) gained 7.8% to close at $0.4960.
- Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 7.4% to close at $5.23. Babcock & Wilcox Construction Co. LLC was awarded $42 million in large North American upgrade projects.
- monday.com Ltd. (NASDAQ: MNDY (NASDAQ:MNDY)) gained 7.3% to settle at $102.10 after the company reported better-than-expected Q3 financial results.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers
- Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) shares tumbled 83.2% to close at $0.6795 on Monday after the company reported topline results from the STS101 SUMMIT Phase 3 efficacy trial in migraine patients.
- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) fell 44% to close at $2.55 after the company reported Q3 earnings results and provided a business update.
- Nuwellis, Inc. (NASDAQ: NUWE) declined 40% to close at $0.12. Nuwellis recently reported worse-than-expected Q3 EPS and sales results.
- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) fell 37.8% to close at $0.7402. Infinity Pharmaceuticals posted a Q3 loss of $0.12 per share. The company also reported an update from its MARIO-3 study of eganelisib in combination with atezolizumab and nab-paclitaxel in front-line metastatic triple-negative breast cancer (TNBC) patients.
- POINT Biopharma Global Inc. (NASDAQ: PNT) dipped 37.4% to settle at $5.72. Lantheus and POINT Biopharma announced collaboration and exclusive license agreements for commercialization of PNT2002 & PNT2003.
- Lumos Pharma, Inc. (NASDAQ: LUMO) fell 34.7% to close at $5.82. Lumos Pharma posted a Q3 loss of $0.86 per share and disclosed interim results from two Phase 2 trials evaluating oral LUM-201 for moderate pediatric growth hormone deficiency.
- Greenwave Technology Solutions, Inc. (NASDAQ: GWAV) dipped 28.6% to settle at $1.0075.
- SOBR Safe, Inc. (NASDAQ: SOBR) declined 28.6% to close at $1.50.
- MorphoSys AG (NASDAQ: MOR) shares dropped 28.1% to close at $3.94. MorphoSys’ licensing partner Roche issued an update on Phase 3 GRADUATE program for Gantenerumab in early Alzheimer’s disease.
- Tremor International Ltd (NASDAQ: TRMR) fell 26.1% to close at $6.52 after gaining over 5% on Friday.
- Stoke Therapeutics, Inc. (NASDAQ: STOK) fell 25.3% to close at $9.33 after the company reported a wider Q3 loss.
- TuanChe Limited (NASDAQ: TC) dropped 24.3% to settle at $7.51.
- Harbor Custom Development, Inc. (NASDAQ: HCDI) dropped 24.1% to close at $0.6601. Harbor Custom Development posted a Q3 loss of $0.37 per share.
- Decisionpoint Systems, Inc. (NYSE: DPSI) dipped 22.8% to close at $5.71 following Q3 results.
- Actelis Networks, Inc. (NASDAQ: ASNS) fell 22.7% to close at $0.6103. Actelis Networks posted a Q3 loss of $0.13 per share.
- 908 Devices Inc. (NASDAQ: MASS) fell 22.1% to settle at $12.48 as the company lowered its FY22 revenue forecast.
- Hudson Global, Inc. (NASDAQ: HSON) dropped 22% to close at $22.00.
- Fast Radius, Inc. (NASDAQ: FSRD) shares declined 19.8% to close at $0.1950 after dropping around 7% on Friday.
- Rail Vision Ltd. (NASDAQ: RVSN) fell 19% to settle at $0.7105.
- AGBA Acquisition Limited (NASDAQ: AGBA) dropped 18.7% to settle at $5.71.
- Alight, Inc. (NASDAQ: ALIT) dropped 18.2% to close at $8.06 after the company announced a 20M share common stock offering.
- Carvana Co. (NYSE: CVNA) declined 18% to close at $9.74.
- Performance Shipping Inc. (NASDAQ: PSHG) declined 17.7% to close at $0.2595. Performance Shipping posted Q3 EPS of $0.10.
- Altus Power, Inc. (NYSE: AMPS) dropped 16.6% to settle at $7.12 following Q3 results.
- Ascendis Pharma A/S (NASDAQ: ASND) fell 16.5% to close at $110.26. Ascendis Pharma announced positive topline results from the ACcomplisH Phase 2 trial of once-weekly TransCon CNP compared to a placebo in children with achondroplasia aged 2 to 10 years old.
- CareMax, Inc. (NASDAQ: CMAX) dipped 16.2% to close at $4.57. CareMax recently posted a Q3 loss of $0.25 per share.
- Latham Group, Inc. (NASDAQ: SWIM) fell 15.4% to settle at $3.52.
- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) dipped 14.9% to close at $7.56.
- Emergent BioSolutions Inc. (NYSE: EBS) fell 14.6% to settle at $13.45.
- Algonquin Power & Utilities Corp. (NYSE: AQN) fell 14.3% to close at $7.97. Algonquin Power & Utilities Corp reported worse-than-expected Q3 EPS. Several analysts downgraded the stock today.
- Pear Therapeutics, Inc. (NASDAQ: PEAR) dropped 13.4% to settle at $2.52. Pear Therapeutics posted a Q3 loss of $0.22 per share.
- 2U, Inc. (NASDAQ: TWOU) dipped 13.1% to close at $7.35.
- Oatly Group (NASDAQ:OTLY) AB (NASDAQ: OTLY) fell 12.7% to close at $2.14 after the company reported worse-than-expected Q3 EPS and sales results.
- Stitch Fix, Inc. (NASDAQ: SFIX) dropped 11.4% to close at $4.13.
- CS Disco, Inc. (NYSE: LAW) declined 11.2% to close at $9.19.
- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) declined 11% to close at $0.6392. TOMI Environmental Solutions recently posted a Q3 loss of $0.03 per share.
- 8x8, Inc. (NYSE: EGHT) fell 10.5% to close at $4.25.
- Transphorm, Inc. (NASDAQ: TGAN) fell 8.5% to close at $6.44.
- 5E Advanced Materials Inc. (NASDAQ: FEAM) dropped 7.3% to close at $11.65. 5E Advanced Materials, on Friday, reported Q1 results.
- Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 5.3% to close at $3.74. Bed Bath & Beyond reported additional privately negotiated senior notes exchanges and concurrent private placement of common stock with several institutional holders.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.